sar425899 sanofi dual glp-1 glucagon agonist Role of a Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor (Twincretin) in Glycemic Control: From Pathophysiology to Treatment Gut hormone polyagonists for the

adults live with obesity, according to the CDC, and many patients exploring treatment options face a fragmented process coordinating provider visits, prescription access, lifestyle changes and insurance considerations across multiple sources

That does not mean GLP-1 medications are a problem

Poor sleep is associated with insulin resistance, increased hunger, and weight gain, which might reduce some benefits of GLP-1s [175]

Human C-cells appear to express far fewer GLP-1 receptors, which may explain why similar tumor patterns have not been consistently observed in clinical populations

its a different mechanism

T.TsaiK